Mounjaro, also known as tirzepatide, is a prescription medication that has gained attention for its effectiveness in weight loss management. Mounjaro is a dual GIP/GLP-1 receptor agonist. It works by mimicking the effects of incretin hormones, which are naturally produced in the gut and help regulate insulin levels. Specifically, it: - ​Increases insulin sensitivity and secretion. - Suppresses glucagon secretion. - Slows gastric emptying, which helps you feel full longer.

Wegovy, known generically as semaglutide, is a medication approved for weight management. Wegovy is a GLP-1 receptor agonist. It mimics the glucagon-like peptide-1 (GLP-1) hormone, which plays a role in appetite regulation and insulin secretion. Specifically, it: - Bind to and activates the GLP-1 receptor to increase insulin secretion. - Slows gastric emptying, leading to prolonged feelings of fullness. - Reduces food intake by decreasing hunger and cravings.

Rybelsus is an oral medication that contains semaglutide, a GLP-1 receptor agonist, and is primarily used to treat type 2 diabetes. However, it has also been found to aid in weight loss and as such is licenced as a weight loss medication. Rybelsus works by mimicking the action of the GLP-1 hormone, which helps to regulate blood sugar levels and appetite. Specifically, it: - Increases insulin production in response to meals. - Decreases the amount of glucose produced by the liver. - Slows down gastric emptying, leading to a feeling of fullness and reduced appetite